OZEMPIC

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug OZEMPIC contains one active pharmaceutical ingredient (API):

1 Semaglutide
UNII 53AXN4NNHX - SEMAGLUTIDE

Semaglutide is a GLP-1 receptor agonist. It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food. This helps with the control of blood glucose levels.

Read about Semaglutide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
OZEMPIC Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BJ06 A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 12075M, 12080T
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526619010010201, 526619010010301
Country: CA Health Products and Food Branch Identifier(s): 02471469, 02471477
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 178-MBE-0221, 190-MBE-0421
Country: EE Ravimiamet Identifier(s): 1764435, 1788509, 1788510, 1788521, 1788532, 1788543, 1873740, 1873751
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1171251003, 1171251005, 117251002
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 123895, 489034, 510642
Country: FR Base de données publique des médicaments Identifier(s): 61400703, 63210923, 65766192
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 364709, 364712, 364715, 380747, 387200, 387202
Country: HK Department of Health Drug Office Identifier(s): 66485, 66486, 66487
Country: IE Health Products Regulatory Authority Identifier(s): 33700, 33701, 33702, 33703, 33704, 33705, 37706, 37707, 37708
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8389, 8390, 8391
Country: IT Agenzia del Farmaco Identifier(s): 046128017, 046128029, 046128031, 046128043, 046128056, 046128068, 046128070, 046128082
Country: JP 医薬品医療機器総合機構 Identifier(s): 2499418G1028, 2499418G2024, 2499418G3020, 2499418G4027
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1085075, 1086013, 1086014, 1086015, 1086016, 1086017
Country: NL Z-Index G-Standaard, PRK Identifier(s): 201650, 201677, 201693
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100401983, 100413822, 100413839
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65785001, W65786001, W65786002, W65787001, W65787002
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699676950300, 8699676950317, 8699676950324, 8699676950362, 8699676950379
Country: US FDA, National Drug Code Identifier(s): 0169-4130, 0169-4132, 0169-4136, 50090-5138, 70518-2143

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.